113 related articles for article (PubMed ID: 8036488)
1. Cancer treatment. Will history repeat for boron capture therapy?
Flam F
Science; 1994 Jul; 265(5171):468-9. PubMed ID: 8036488
[No Abstract] [Full Text] [Related]
2. Tolerance of normal human brain to boron neutron capture therapy.
Coderre JA; Hopewell JW; Turcotte JC; Riley KJ; Binns PJ; Kiger WS; Harling OK
Appl Radiat Isot; 2004 Nov; 61(5):1083-7. PubMed ID: 15308196
[TBL] [Abstract][Full Text] [Related]
3. Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Kageji T; Mizobuchi Y; Nagahiro S; Nakagawa Y; Kumada H
Appl Radiat Isot; 2014 Jun; 88():20-2. PubMed ID: 24480727
[TBL] [Abstract][Full Text] [Related]
4. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
5. L-boronophenylalanine-mediated boron neutron capture therapy for malignant glioma progressing after external beam radiation therapy: a Phase I study.
Kankaanranta L; Seppälä T; Koivunoro H; Välimäki P; Beule A; Collan J; Kortesniemi M; Uusi-Simola J; Kotiluoto P; Auterinen I; Serèn T; Paetau A; Saarilahti K; Savolainen S; Joensuu H
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):369-76. PubMed ID: 21236605
[TBL] [Abstract][Full Text] [Related]
6. Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme.
Aziz T; Peress NS; Diaz A; Capala J; Chanana A
J Neuropathol Exp Neurol; 2000 Jan; 59(1):62-73. PubMed ID: 10744036
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy for cancer.
Barth RF; Soloway AH; Fairchild RG
Sci Am; 1990 Oct; 263(4):100-3, 106-7. PubMed ID: 2173134
[No Abstract] [Full Text] [Related]
8. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Bergenheim AT; Capala J; Roslin M; Henriksson R
J Neurooncol; 2005 Feb; 71(3):287-93. PubMed ID: 15735919
[TBL] [Abstract][Full Text] [Related]
9. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
10. Boron neutron capture therapy of primary and metastatic brain tumors.
Barth RF; Soloway AH
Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
[TBL] [Abstract][Full Text] [Related]
11. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Kabalka GW; Smith GT; Dyke JP; Reid WS; Longford CP; Roberts TG; Reddy NK; Buonocore E; Hübner KF
J Nucl Med; 1997 Nov; 38(11):1762-7. PubMed ID: 9374349
[TBL] [Abstract][Full Text] [Related]
13. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine.
Yang W; Barth RF; Bartus RT; Rotaru JH; Moeschberger ML; Ferketich AK; Nawrocky MM; Coderre JA; Goodman JH
Neurosurgery; 2000 Jul; 47(1):189-97; discussion 197-8. PubMed ID: 10917362
[TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy at the crossroads: challenges and opportunities.
Barth RF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
[TBL] [Abstract][Full Text] [Related]
15. A proposed protocol for clinical trials of boron neutron capture therapy in glioblastoma multiforme.
Dorn RV; Spickard JH; Griebenow ML
Basic Life Sci; 1989; 50():135-44. PubMed ID: 2546532
[No Abstract] [Full Text] [Related]
16. Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS.
Aldossari S; McMahon G; Lockyer NP; Moore KL
Analyst; 2019 Nov; 144(21):6214-6224. PubMed ID: 31528921
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
18. Case numbers for a randomized clinical trial of boron neutron capture therapy for Glioblastoma multiforme.
Sander A; Wosniok W; Gabel D
Appl Radiat Isot; 2014 Jun; 88():16-9. PubMed ID: 24373823
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy for murine malignant gliomas.
Saris SC; Solares GR; Wazer DE; Cano G; Kerley SE; Joyce MA; Adelman LS; Harling OK; Madoc-Jones H; Zamenhof RG
Cancer Res; 1992 Sep; 52(17):4672-7. PubMed ID: 1511433
[TBL] [Abstract][Full Text] [Related]
20. [Neutron capture therapy for cancer].
Fukuda H; Ichihashi M; Mishima Y
Gan To Kagaku Ryoho; 1994 Feb; 21(3):374-8. PubMed ID: 8109994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
